Last updated: 5 September 2024 at 5:42pm EST

Dr. Xiaobin Wu Ph.D. Net Worth




The estimated Net Worth of Xiaobin Wu is at least 30.5 百万$ dollars as of 1 May 2019. Dr Wu owns over 5,955 units of BeiGene Ltd stock worth over 3,666,620$ and over the last 7 years he sold BGNE stock worth over 25,604,663$. In addition, he makes 1,225,407$ as Pres、 COO & GM of China at BeiGene Ltd.

Dr D BGNE stock SEC Form 4 insiders trading

Dr has made over 25 trades of the BeiGene Ltd stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 5,556 units of BGNE stock worth 1,053,695$ on 3 September 2024.

The largest trade he's ever made was selling 10,180 units of BeiGene Ltd stock on 6 July 2021 worth over 3,313,895$. On average, Dr trades about 3,412 units every 63 days since 2018. As of 1 May 2019 he still owns at least 17,365 units of BeiGene Ltd stock.

You can see the complete history of Dr Wu stock trades at the bottom of the page.





Dr. Xiaobin Wu Ph.D. biography

Dr. Xiaobin Wu Ph.D. is the Pres, COO & GM of China at BeiGene Ltd.

What is the salary of Dr D?

As the Pres、 COO & GM of China of BeiGene Ltd, the total compensation of Dr D at BeiGene Ltd is 1,225,407$. There are 4 executives at BeiGene Ltd getting paid more, with John Oyler having the highest compensation of 13,899,000$.



How old is Dr D?

Dr D is 59, he's been the Pres、 COO & GM of China of BeiGene Ltd since . There are 5 older and 16 younger executives at BeiGene Ltd. The oldest executive at BeiGene Ltd is Donald Glazer, 75, who is the Non-Executive Independent Director.

What's Dr D's mailing address?

Xiaobin's mailing address filed with the SEC is C/O MOURANT GOVERNANCE SERVICES (CAYMAN), 94 SOLARIS AVENUE, CAMANA BAY, GRAND CAYMAN, E9, KY1-1108.

Insiders trading at BeiGene Ltd

Over the last 9 years, insiders at BeiGene Ltd have traded over 1,899,158,980$ worth of BeiGene Ltd stock and bought 23,241,738 units worth 1,040,248,444$ . The most active insiders traders include Bros. Advisors Lp667, L.P.B...、Investment Management, Ltd....、Bros. Advisors Lp Baker Bro.... On average, BeiGene Ltd executives and independent directors trade stock every 13 days with the average trade being worth of 33,382,815$. The most recent stock trade was executed by Xiaobin Wu on 3 September 2024, trading 5,556 units of BGNE stock currently worth 1,053,695$.



What does BeiGene Ltd do?

BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.



Complete history of Dr Wu stock trades at BeiGene Ltd

インサイダー
取引
取引
 合計金額
Xiaobin Wu
社長、COO、GM China
 販売 1,053,695$
3 Sep 2024
Xiaobin Wu
社長、COO、GM China
 販売 233,134$
24 Jun 2024
Xiaobin Wu
社長、COO、GM China
 販売 505,216$
17 Jun 2024
Xiaobin Wu
社長、COO、GM China
 販売 272,643$
26 Jun 2023
Xiaobin Wu
社長、COO、GM China
 販売 337,347$
15 Jun 2023
Xiaobin Wu
社長、COO、GM China
 販売 739,586$
7 Jun 2023
Xiaobin Wu
社長、COO、GM China
 販売 1,776,040$
8 May 2023
Xiaobin Wu
社長、COO、GM China
 販売 226,496$
17 Jun 2022
Xiaobin Wu
社長、COO、GM China
 販売 484,186$
6 Jun 2022
Xiaobin Wu
社長、COO、GM China
 販売 1,105,254$
5 May 2022
Xiaobin Wu
社長、COO、GM China
 販売 3,582,700$
8 Nov 2021
Xiaobin Wu
社長、COO、GM China
 販売 3,313,895$
6 Jul 2021
Xiaobin Wu
社長、COO、GM China
 販売 382,555$
16 Jun 2021
Xiaobin Wu
社長、COO、GM China
 販売 1,197,931$
7 Jun 2021
Xiaobin Wu
社長、COO、GM China
 販売 2,303,245$
3 May 2021
Xiaobin Wu
社長、COO、GM China
 販売 1,200,000$
5 Oct 2020
Xiaobin Wu
社長、COO、GM China
 販売 1,121,400$
25 Sep 2020
Xiaobin Wu
社長、COO、GM China
 販売 1,041,320$
17 Sep 2020
Xiaobin Wu
社長、COO、GM China
 販売 822,426$
17 Jul 2020
Xiaobin Wu
社長、COO、GM China
 販売 1,311,000$
13 Jul 2020
Xiaobin Wu
社長、COO、GM China
 販売 478,324$
8 Jun 2020
Xiaobin Wu
社長、COO、GM China
 販売 992,702$
1 May 2020
Xiaobin Wu
社長、COO、GM China
 販売 202,050$
15 Nov 2019
Xiaobin Wu
社長、COO、GM China
 販売 180,000$
1 Nov 2019
Xiaobin Wu
社長、COO、GM China
 販売 741,517$
1 May 2019


BeiGene Ltd executives and stock owners

BeiGene Ltd executives and other stock owners filed with the SEC include: